Symbol:
Lyar
Name:
Ly1 antibody reactive
RGD ID:
1305352
Description:
Predicted to enable several functions, including DNA-binding transcription factor binding activity; identical protein binding activity; and transcription regulator inhibitor activity. Predicted to be involved in several processes, including erythrocyte development; positive regulation of phagocytosis; and regulation of DNA-templated transcription. Predicted to be located in nucleoplasm and photoreceptor outer segment. Predicted to be active in nucleolus. Orthologous to human LYAR (Ly1 antibody reactive); INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
cell growth-regulating nucleolar protein; LOC289707; Ly1 antibody reactive clone; Ly1 antibody reactive homolog; Ly1 antibody reactive homolog (mouse)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LYAR (Ly1 antibody reactive)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Lyar (Ly1 antibody reactive clone)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lyar (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LYAR (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LYAR (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lyar (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LYAR (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LYAR (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lyar (Ly1 antibody reactive)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
HMCN1 (hemicentin 1)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Lyar (Ly1 antibody reactive clone)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
LYAR (Ly1 antibody reactive)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lyar (Ly1 antibody reactive homolog (mouse))
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG12909
Alliance
DIOPT (Ensembl Compara|Hieranoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
C16C10.8
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
YCR087C-A
Alliance
DIOPT (Ensembl Compara|OrthoInspector|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
lyar
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 76,789,193 - 76,802,973 (-) NCBI GRCr8 mRatBN7.2 14 72,576,878 - 72,590,854 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 72,576,879 - 72,590,612 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 77,018,568 - 77,032,136 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 78,259,442 - 78,273,010 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 74,699,518 - 74,713,086 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 77,308,211 - 77,321,931 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 77,308,204 - 77,321,977 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 77,290,073 - 77,303,793 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 77,859,637 - 77,873,205 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 77,862,030 - 77,875,596 (-) NCBI Celera 14 71,527,386 - 71,540,966 (-) NCBI Celera Cytogenetic Map 14 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lyar Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYAR mRNA] CTD PMID:31150632 Lyar Rat 1,2-dimethylhydrazine increases expression ISO Lyar (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of LYAR mRNA CTD PMID:22206623 Lyar Rat 17alpha-ethynylestradiol multiple interactions ISO Lyar (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LYAR mRNA CTD PMID:17942748 Lyar Rat 17alpha-ethynylestradiol increases expression ISO Lyar (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of LYAR mRNA CTD PMID:17942748 Lyar Rat 17beta-estradiol increases expression ISO LYAR (Homo sapiens) 6480464 Estradiol results in increased expression of LYAR mRNA CTD PMID:23019147 more ... Lyar Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of LYAR mRNA CTD PMID:32145629 Lyar Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lyar (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LYAR mRNA CTD PMID:17942748 Lyar Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LYAR mRNA CTD PMID:34747641 Lyar Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lyar (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LYAR mRNA CTD PMID:21570461 Lyar Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO LYAR (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LYAR mRNA CTD PMID:20106945 and PMID:21632981 Lyar Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lyar (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LYAR mRNA CTD PMID:17942748 and PMID:19465110 Lyar Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of LYAR mRNA CTD PMID:21346803 Lyar Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of LYAR mRNA CTD PMID:21346803 Lyar Rat 2-methylcholine affects expression ISO LYAR (Homo sapiens) 6480464 beta-methylcholine affects the expression of LYAR mRNA CTD PMID:21179406 Lyar Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 Lyar Rat 4,4'-diaminodiphenylmethane decreases expression ISO Lyar (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of LYAR mRNA CTD PMID:18648102 Lyar Rat 4,4'-sulfonyldiphenol increases expression ISO Lyar (Mus musculus) 6480464 bisphenol S results in increased expression of LYAR mRNA CTD PMID:39298647 Lyar Rat 4,4'-sulfonyldiphenol increases expression ISO LYAR (Homo sapiens) 6480464 bisphenol S results in increased expression of LYAR protein CTD PMID:31945527 Lyar Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LYAR mRNA CTD PMID:30047161 Lyar Rat acrolein multiple interactions ISO LYAR (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LYAR mRNA CTD PMID:32845096 Lyar Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of LYAR mRNA CTD PMID:28959563 Lyar Rat aflatoxin B1 increases methylation ISO LYAR (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of LYAR gene CTD PMID:27153756 Lyar Rat aflatoxin B1 increases expression ISO LYAR (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of LYAR mRNA CTD PMID:22100608 and PMID:27153756 Lyar Rat all-trans-retinoic acid decreases expression ISO LYAR (Homo sapiens) 6480464 Tretinoin results in decreased expression of LYAR mRNA CTD PMID:23724009 and PMID:33167477 Lyar Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of LYAR mRNA CTD PMID:30047161 Lyar Rat antirheumatic drug decreases expression ISO LYAR (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of LYAR mRNA CTD PMID:24449571 Lyar Rat Aroclor 1254 decreases expression ISO Lyar (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of LYAR mRNA CTD PMID:23650126 Lyar Rat arsane multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat arsenic atom multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat arsenite(3-) decreases expression ISO Lyar (Mus musculus) 6480464 arsenite results in decreased expression of LYAR protein CTD PMID:37955338 Lyar Rat azoxystrobin decreases expression ISO LYAR (Homo sapiens) 6480464 azoxystrobin results in decreased expression of LYAR mRNA CTD PMID:33512557 Lyar Rat benzo[a]pyrene increases expression ISO Lyar (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LYAR mRNA CTD PMID:22228805 Lyar Rat benzo[a]pyrene increases expression ISO LYAR (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of LYAR mRNA CTD PMID:32234424 Lyar Rat benzo[a]pyrene decreases expression ISO LYAR (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of LYAR mRNA CTD PMID:22316170 Lyar Rat benzo[a]pyrene diol epoxide I increases expression ISO LYAR (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 Lyar Rat bis(2-chloroethyl) sulfide decreases expression ISO LYAR (Homo sapiens) 6480464 Mustard Gas results in decreased expression of LYAR mRNA CTD PMID:25102026 Lyar Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LYAR mRNA CTD PMID:25181051 and PMID:34947998 Lyar Rat bisphenol A increases expression ISO LYAR (Homo sapiens) 6480464 bisphenol A results in increased expression of LYAR mRNA CTD PMID:36232920 and PMID:36828454 Lyar Rat bisphenol A increases methylation ISO LYAR (Homo sapiens) 6480464 bisphenol A results in increased methylation of LYAR gene CTD PMID:31601247 Lyar Rat bisphenol A decreases expression ISO Lyar (Mus musculus) 6480464 bisphenol A results in decreased expression of LYAR mRNA CTD PMID:33221593 Lyar Rat bisphenol A decreases expression ISO LYAR (Homo sapiens) 6480464 bisphenol A results in decreased expression of LYAR mRNA CTD PMID:29275510 Lyar Rat bisphenol F decreases expression ISO Lyar (Mus musculus) 6480464 bisphenol F results in decreased expression of LYAR mRNA CTD PMID:38685157 Lyar Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of LYAR mRNA CTD PMID:19167457 Lyar Rat cadmium atom multiple interactions ISO LYAR (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LYAR mRNA CTD PMID:35301059 Lyar Rat cadmium dichloride multiple interactions ISO LYAR (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LYAR mRNA CTD PMID:35301059 Lyar Rat calcitriol decreases expression ISO LYAR (Homo sapiens) 6480464 Calcitriol results in decreased expression of LYAR mRNA CTD PMID:21592394 Lyar Rat calcitriol multiple interactions ISO LYAR (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of LYAR mRNA CTD PMID:21592394 Lyar Rat chlorpyrifos decreases expression ISO Lyar (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of LYAR mRNA CTD PMID:37019170 Lyar Rat chromium(6+) affects expression ISO Lyar (Mus musculus) 6480464 chromium hexavalent ion affects the expression of LYAR mRNA CTD PMID:28472532 Lyar Rat copper atom multiple interactions ISO LYAR (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LYAR mRNA CTD PMID:20971185 Lyar Rat copper atom affects binding ISO LYAR (Homo sapiens) 6480464 LYAR protein binds to Copper CTD PMID:15359738 Lyar Rat copper(0) multiple interactions ISO LYAR (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LYAR mRNA CTD PMID:20971185 Lyar Rat copper(0) affects binding ISO LYAR (Homo sapiens) 6480464 LYAR protein binds to Copper CTD PMID:15359738 Lyar Rat copper(II) chloride increases expression ISO LYAR (Homo sapiens) 6480464 cupric chloride results in increased expression of LYAR mRNA CTD PMID:38568856 Lyar Rat coumarin decreases phosphorylation ISO LYAR (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of LYAR protein CTD PMID:35688186 Lyar Rat coumestrol increases expression ISO LYAR (Homo sapiens) 6480464 Coumestrol results in increased expression of LYAR mRNA CTD PMID:19167446 Lyar Rat cyclosporin A increases expression ISO LYAR (Homo sapiens) 6480464 Cyclosporine results in increased expression of LYAR mRNA CTD PMID:20106945 and PMID:27989131 Lyar Rat dioxygen decreases expression ISO LYAR (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of LYAR mRNA CTD PMID:26516004 Lyar Rat dioxygen multiple interactions ISO Lyar (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYAR mRNA CTD PMID:30529165 Lyar Rat diuron decreases expression ISO LYAR (Homo sapiens) 6480464 Diuron results in decreased expression of LYAR mRNA CTD PMID:35967413 Lyar Rat enzyme inhibitor multiple interactions ISO LYAR (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LYAR protein CTD PMID:23301498 Lyar Rat ethanol decreases expression ISO LYAR (Homo sapiens) 6480464 Ethanol results in decreased expression of LYAR mRNA CTD PMID:23378141 Lyar Rat ethyl methanesulfonate decreases expression ISO LYAR (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of LYAR mRNA CTD PMID:23649840 Lyar Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of LYAR mRNA CTD PMID:24136188 Lyar Rat folic acid decreases expression ISO Lyar (Mus musculus) 6480464 Folic Acid results in decreased expression of LYAR mRNA CTD PMID:25629700 Lyar Rat formaldehyde decreases expression ISO LYAR (Homo sapiens) 6480464 Formaldehyde results in decreased expression of LYAR mRNA CTD PMID:23649840 Lyar Rat FR900359 affects phosphorylation ISO LYAR (Homo sapiens) 6480464 FR900359 affects the phosphorylation of LYAR protein CTD PMID:37730182 Lyar Rat hydrogen peroxide affects expression ISO LYAR (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of LYAR mRNA CTD PMID:20044591 Lyar Rat ivermectin decreases expression ISO LYAR (Homo sapiens) 6480464 Ivermectin results in decreased expression of LYAR protein CTD PMID:32959892 Lyar Rat manganese atom multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat manganese(0) multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat manganese(II) chloride multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat menadione affects expression ISO LYAR (Homo sapiens) 6480464 Vitamin K 3 affects the expression of LYAR mRNA CTD PMID:20044591 Lyar Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of LYAR mRNA CTD PMID:30047161 Lyar Rat methyl methanesulfonate decreases expression ISO LYAR (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of LYAR mRNA CTD PMID:23649840 Lyar Rat methylmercury chloride increases expression ISO LYAR (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of LYAR mRNA CTD PMID:28001369 Lyar Rat nickel atom increases expression ISO LYAR (Homo sapiens) 6480464 Nickel results in increased expression of LYAR mRNA CTD PMID:24768652 and PMID:25583101 Lyar Rat nitrates multiple interactions ISO Lyar (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LYAR mRNA CTD PMID:35964746 Lyar Rat ozone multiple interactions ISO LYAR (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LYAR mRNA CTD PMID:32845096 Lyar Rat paracetamol decreases expression ISO LYAR (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LYAR mRNA CTD PMID:22230336 Lyar Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of LYAR mRNA CTD PMID:32680482 Lyar Rat pentachlorophenol increases expression ISO Lyar (Mus musculus) 6480464 Pentachlorophenol results in increased expression of LYAR mRNA CTD PMID:23892564 Lyar Rat phenobarbital affects expression ISO LYAR (Homo sapiens) 6480464 Phenobarbital affects the expression of LYAR mRNA CTD PMID:19159669 Lyar Rat pirinixic acid increases expression ISO Lyar (Mus musculus) 6480464 pirinixic acid results in increased expression of LYAR mRNA CTD PMID:18301758 Lyar Rat resveratrol decreases expression ISO Lyar (Mus musculus) 6480464 resveratrol results in decreased expression of LYAR protein CTD PMID:25505154 Lyar Rat rotenone decreases expression ISO LYAR (Homo sapiens) 6480464 Rotenone results in decreased expression of LYAR mRNA CTD PMID:33512557 Lyar Rat SB 431542 multiple interactions ISO LYAR (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LYAR protein CTD PMID:37664457 Lyar Rat silicon dioxide increases expression ISO LYAR (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of LYAR mRNA CTD PMID:25895662 Lyar Rat sodium arsenite decreases expression ISO LYAR (Homo sapiens) 6480464 sodium arsenite results in decreased expression of LYAR mRNA CTD PMID:38568856 Lyar Rat sodium arsenite multiple interactions ISO LYAR (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA CTD PMID:39836092 Lyar Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of LYAR mRNA CTD PMID:22110744 Lyar Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of LYAR mRNA CTD PMID:30047161 Lyar Rat sunitinib increases expression ISO LYAR (Homo sapiens) 6480464 Sunitinib results in increased expression of LYAR mRNA CTD PMID:31533062 Lyar Rat testosterone multiple interactions ISO LYAR (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of LYAR mRNA CTD PMID:21592394 Lyar Rat testosterone decreases expression ISO LYAR (Homo sapiens) 6480464 Testosterone results in decreased expression of LYAR mRNA CTD PMID:21592394 Lyar Rat tetrachloromethane increases expression ISO Lyar (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LYAR mRNA CTD PMID:27339419 and PMID:31919559 Lyar Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYAR mRNA] CTD PMID:31150632 Lyar Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LYAR mRNA CTD PMID:31150632 Lyar Rat thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of LYAR protein CTD PMID:35544339 Lyar Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LYAR mRNA CTD PMID:34492290 Lyar Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LYAR mRNA CTD PMID:33387578 Lyar Rat trimellitic anhydride increases expression ISO Lyar (Mus musculus) 6480464 trimellitic anhydride results in increased expression of LYAR mRNA CTD PMID:19042947 Lyar Rat triptonide affects expression ISO Lyar (Mus musculus) 6480464 triptonide affects the expression of LYAR mRNA CTD PMID:33045310 Lyar Rat valproic acid increases expression ISO LYAR (Homo sapiens) 6480464 Valproic Acid results in increased expression of LYAR mRNA CTD PMID:29154799 Lyar Rat valproic acid affects expression ISO LYAR (Homo sapiens) 6480464 Valproic Acid affects the expression of LYAR mRNA CTD PMID:25979313 Lyar Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LYAR mRNA CTD PMID:23034163 Lyar Rat zearalenone increases expression ISO LYAR (Homo sapiens) 6480464 Zearalenone results in increased expression of LYAR mRNA CTD PMID:36828454
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-methylcholine (ISO) 3,3',4,4',5-pentachlorobiphenyl (EXP) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) acrolein (ISO) acrylamide (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) antirheumatic drug (ISO) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) azoxystrobin (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (ISO) calcitriol (ISO) chlorpyrifos (ISO) chromium(6+) (ISO) copper atom (ISO) copper(0) (ISO) copper(II) chloride (ISO) coumarin (ISO) coumestrol (ISO) cyclosporin A (ISO) dioxygen (ISO) diuron (ISO) enzyme inhibitor (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) flutamide (EXP) folic acid (ISO) formaldehyde (ISO) FR900359 (ISO) hydrogen peroxide (ISO) ivermectin (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) menadione (ISO) methimazole (EXP) methyl methanesulfonate (ISO) methylmercury chloride (ISO) nickel atom (ISO) nitrates (ISO) ozone (ISO) paracetamol (ISO) paraquat (EXP) pentachlorophenol (ISO) phenobarbital (ISO) pirinixic acid (ISO) resveratrol (ISO) rotenone (ISO) SB 431542 (ISO) silicon dioxide (ISO) sodium arsenite (ISO) sodium dichromate (EXP) sulfadimethoxine (EXP) sunitinib (ISO) testosterone (ISO) tetrachloromethane (EXP,ISO) thapsigargin (EXP) thioacetamide (EXP) trichloroethene (EXP) trimellitic anhydride (ISO) triptonide (ISO) valproic acid (ISO) vinclozolin (EXP) zearalenone (ISO)
Biological Process
erythrocyte development (IEA,ISO,ISS) immune system process (IEA) innate immune response (IEA) negative regulation of innate immune response (IEA,ISO) negative regulation of transcription by RNA polymerase II (IBA,IEA,ISO,ISS) positive regulation of phagocytosis (IEA,ISO,ISS) positive regulation of transcription by RNA polymerase I (IEA,ISO) rRNA processing (IBA,IEA,ISO,ISS)
Lyar (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 76,789,193 - 76,802,973 (-) NCBI GRCr8 mRatBN7.2 14 72,576,878 - 72,590,854 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 72,576,879 - 72,590,612 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 77,018,568 - 77,032,136 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 78,259,442 - 78,273,010 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 74,699,518 - 74,713,086 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 77,308,211 - 77,321,931 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 77,308,204 - 77,321,977 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 77,290,073 - 77,303,793 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 77,859,637 - 77,873,205 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 77,862,030 - 77,875,596 (-) NCBI Celera 14 71,527,386 - 71,540,966 (-) NCBI Celera Cytogenetic Map 14 q21 NCBI
LYAR (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 4 4,267,701 - 4,290,154 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 4 4,267,701 - 4,290,154 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 4 4,269,428 - 4,291,881 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 4 4,320,337 - 4,342,744 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 4 4,167,051 - 4,189,521 (-) NCBI Celera Cytogenetic Map 4 p16.3 NCBI HuRef 4 4,205,115 - 4,227,579 (-) NCBI HuRef CHM1_1 4 4,267,309 - 4,289,782 (-) NCBI CHM1_1 T2T-CHM13v2.0 4 4,237,159 - 4,259,618 (-) NCBI T2T-CHM13v2.0
Lyar (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 38,377,815 - 38,391,650 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 38,377,814 - 38,391,650 (+) Ensembl GRCm39 Ensembl GRCm38 5 38,220,471 - 38,234,306 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 38,220,470 - 38,234,306 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 38,611,721 - 38,625,545 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 38,508,799 - 38,522,546 (+) NCBI MGSCv36 mm8 Celera 5 35,670,252 - 35,684,076 (+) NCBI Celera Cytogenetic Map 5 B3 NCBI cM Map 5 20.29 NCBI
Lyar (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955514 5,358,843 - 5,376,112 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955514 5,358,843 - 5,375,990 (+) NCBI ChiLan1.0 ChiLan1.0
LYAR (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 3 4,534,513 - 4,557,030 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 4 4,467,357 - 4,489,984 (-) NCBI NHGRI_mPanPan1 PanPan1.1 4 4,348,263 - 4,370,716 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 4 4,348,263 - 4,364,347 (-) Ensembl panpan1.1 panPan2
LYAR (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 3 69,710,735 - 69,724,175 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 3 69,710,735 - 69,724,177 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 3 72,262,732 - 72,281,663 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 3 70,467,687 - 70,486,622 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 3 70,467,692 - 70,486,574 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 3 69,741,785 - 69,760,718 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 3 69,906,935 - 69,925,842 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 3 70,288,339 - 70,307,278 (-) NCBI UU_Cfam_GSD_1.0
Lyar (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
LYAR (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 8 6,081,368 - 6,099,857 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 8 6,081,332 - 6,099,861 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 8 5,776,295 - 5,794,805 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LYAR (Chlorocebus sabaeus - green monkey)
Lyar (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 15 Count of miRNA genes: 12 Interacting mature miRNAs: 14 Transcripts: ENSRNOT00000007154 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2313089 Bss81 Bone structure and strength QTL 81 3.4 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 14 37669719 82669719 Rat 9590294 Uminl4 Urine mineral level QTL 4 5.66 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 14 55624247 100624247 Rat 2300197 Scl59 Serum cholesterol level QTL 59 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 14 55147478 100147478 Rat 70214 Niddm28 Non-insulin dependent diabetes mellitus QTL 28 4.06 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 39998251 75582726 Rat 70153 Bp59 Blood pressure QTL 59 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 14 68757796 83368335 Rat 70187 Pancm5 Pancreatic morphology QTL 5 16.7 pancreas mass (VT:0010144) pancreas weight to body weight ratio (CMO:0000630) 14 30320092 80829842 Rat 631523 Pia13 Pristane induced arthritis QTL 13 3.3 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 14 40793460 98037301 Rat 1582259 Gluco23 Glucose level QTL 23 3.1 0.0008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 70053989 104886043 Rat 2313100 Bss82 Bone structure and strength QTL 82 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 14 37669719 82669719 Rat 634328 Hc5 Hypercalciuria QTL 5 2.3 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 14 58184885 103184885 Rat 2317879 Alcrsp27 Alcohol response QTL 27 3.3 0.63 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 14 56631369 101631369 Rat 1641900 Alcrsp11 Alcohol response QTL 11 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 14 70053989 104886043 Rat 631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 3.37 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 11030622 95876975 Rat 9589034 Epfw11 Epididymal fat weight QTL 11 6 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 14 55624247 100624247 Rat 2313048 Bss84 Bone structure and strength QTL 84 3.1 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 14 37669719 82669719 Rat 1300136 Rf22 Renal function QTL 22 3.9 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 14 42262529 95023211 Rat 1549834 Scl45 Serum cholesterol level QTL 45 5.8 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 14 50023211 95023211 Rat 738037 Hcas6 Hepatocarcinoma susceptibility QTL 6 2.93 liver integrity trait (VT:0010547) liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) 14 39057237 83368335 Rat 2313084 Bss83 Bone structure and strength QTL 83 2.9 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 14 37669719 82669719 Rat
BE111765
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 72,576,960 - 72,577,115 (+) MAPPER mRatBN7.2 Rnor_6.0 14 77,308,294 - 77,308,448 NCBI Rnor6.0 Rnor_5.0 14 77,290,156 - 77,290,310 UniSTS Rnor5.0 RGSC_v3.4 14 77,859,716 - 77,859,870 UniSTS RGSC3.4 Celera 14 71,527,465 - 71,527,619 UniSTS Cytogenetic Map 14 q21 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000007154 ⟹ ENSRNOP00000007154
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 72,576,879 - 72,590,612 (-) Ensembl Rnor_6.0 Ensembl 14 77,308,218 - 77,321,783 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000084093 ⟹ ENSRNOP00000073585
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 72,577,497 - 72,590,612 (-) Ensembl Rnor_6.0 Ensembl 14 77,308,204 - 77,321,977 (-) Ensembl
RefSeq Acc Id:
NM_001011911 ⟹ NP_001011911
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,197 - 76,802,765 (-) NCBI mRatBN7.2 14 72,576,882 - 72,590,451 (-) NCBI Rnor_6.0 14 77,308,215 - 77,321,783 (-) NCBI Rnor_5.0 14 77,290,073 - 77,303,793 (-) NCBI RGSC_v3.4 14 77,859,637 - 77,873,205 (-) RGD Celera 14 71,527,386 - 71,540,966 (-) RGD
Sequence:
GGCGGCATGGCCGCCTTCCTTGAGGACTCGCTCGCGGGCAAAATCTGGAGTTCTGAGCTGGAGACGTTGCATCCCGGTTTTTAGTCCGGCCCGATGGCATGGGCAAGAGTTCAAACCTGTATCAGAAA ATATTTAATCATTTAACCAAAAATGGTATTTTTTACATGCAATGCATGTGGTGAATCCGTGAAGAAAATACAGGTGGAAAAGCACGTGTCTATTTGCAGAAACTGTGAATGTCTTTCTTGCATTGACT GTGGGAAAGATTTCTGGGGTGACGACTACAAAAACCATGTGAAATGCATCAGTGAAGATCAGAAATACGGAGGCAAAGGCTATGAAGCCAAAACACACAAAGGTGATGTGAAACAGCAGGCATGGATT CAGAAAATTAATGAGTTAATAAAGAAACCCAACGTCAGCCCCAAGGTGCGAGAACTTTTGCAGCAAATTAGTGCTTTTGACAATGTTCCCAGAAAAAAGGCGAAGTTTCAGAACTGGATGAGGAACAG CCTGAAAGTGCACAGCGACTCTGTTCTGGAGCAGGTGTGGAACATCTTCTCCGAAGCAGCCAGCAGCGAGCAAGATCAGCAGCCACCCAGCCACATGGCAAAGCCAAATACAGAGGTCCCCACTAAGG TTCCATCCACAAAAACAAATGGCACCACAGAGGAGCAAACAGAGGCAAAGAAGAATAAAAGAGAAAGGAAGGAAGAACGACAGAAGAGCAGGAAGAAAGAGAAGAAAGAGCTGAAGTTAGAAAACCAC CAGGAAAATCTGAAGGGCCAGAAGCCAAAGAAGCGCAAAAAGGGCCAGGAGGCCGGACATGAGGCTGGTGGGGAGGATGCCGCGGAGGCCAACGGCGCCCCAGAGAAGAAGAGAGCCCGGGATGCACA GGCTTCTGAAGAGGGAGCAGACAGAAATGGGGGCCCCGCGGAGGATGCTGATGAGGGGCCGACCAAGACAGCAGCAGGAAAACGGAAGCGGCAAAAGCACTCAGAAGTTGAGTCTGATAACAAGAAAA AAAAGATGAAGTTGCCAGGGCAGCCTGAAGAGGGAGAGCCTGAGGACCATGAGGCTCCATCAAAAGGTAAATTCAACTGGAAGGGGACCATTAAAGCTGTTCTGAAACAGGCTCCAGACAACGAGATA TCAGTCAAGAAGTTAAAGAAAAAGGTTATAGCTCAGTACCATGCGGTGATGAGTGACCATCACACATCGGAGGAGGAGCTCCTGGCCATCTTCAACAAGAAGATCAGCAGGAACCCCACCTTTAAGGT GCTGAAGGACAAAGTTAAGCTTCTGAAGTGAGGGCTCTGTTGCGTCACACTCTACCATCCTATTGGCTACTTTCCTCTCTTTGTAAAATGTGTAATGAATTCTAACAGCCGGAAGATTGCTTCCTGAA ACTTTTTAAGTTAAGGAAAAAATATATTTTTGTTAAAACTTTTATGAAAAAATAAAATATATCCTTGTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006251087 ⟹ XP_006251149
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,193 - 76,802,973 (-) NCBI mRatBN7.2 14 72,576,878 - 72,590,854 (-) NCBI Rnor_6.0 14 77,308,211 - 77,321,931 (-) NCBI Rnor_5.0 14 77,290,073 - 77,303,793 (-) NCBI
Sequence:
TTCTGCGCGGGGAAGCTGGGCGAGCCGGTGGCGGTGCTTCGCTGGGCGGCTGCAGCTCCACGTGCTCCTGGCGGCCGGTTGGGACCGTTGGCGGGGTCGGCTGAGAGGGCAAGAGTTCAAACCTGTAT CAGAAAATATTTAATCATTTAACCAAAAATGGTATTTTTTACATGCAATGCATGTGGTGAATCCGTGAAGAAAATACAGGTGGAAAAGCACGTGTCTATTTGCAGAAACTGTGAATGTCTTTCTTGCA TTGACTGTGGGAAAGATTTCTGGGGTGACGACTACAAAAACCATGTGAAATGCATCAGTGAAGATCAGAAATACGGAGGCAAAGGCTATGAAGCCAAAACACACAAAGGTGATGTGAAACAGCAGGCA TGGATTCAGAAAATTAATGAGTTAATAAAGAAACCCAACGTCAGCCCCAAGGTGCGAGAACTTTTGCAGCAAATTAGTGCTTTTGACAATGTTCCCAGAAAAAAGGCGAAGTTTCAGAACTGGATGAG GAACAGCCTGAAAGTGCACAGCGACTCTGTTCTGGAGCAGGTGTGGAACATCTTCTCCGAAGCAGCCAGCAGCGAGCAAGATCAGCAGCCACCCAGCCACATGGCAAAGCCAAATACAGAGGTCCCCA CTAAGGTTCCATCCACAAAAACAAATGGCACCACAGAGGAGCAAACAGAGGCAAAGAAGAATAAAAGAGAAAGGAAGGAAGAACGACAGAAGAGCAGGAAGAAAGAGAAGAAAGAGCTGAAGTTAGAA AACCACCAGGAAAATCTGAAGGGCCAGAAGCCAAAGAAGCGCAAAAAGGGCCAGGAGGCCGGACATGAGGCTGGTGGGGAGGATGCCGCGGAGGCCAACGGCGCCCCAGAGAAGAAGAGAGCCCGGGA TGCACAGGCTTCTGAAGAGGGAGCAGACAGAAATGGGGGCCCCGCGGAGGATGCTGATGAGGGGCCGACCAAGACAGCAGCAGGAAAACGGAAGCGGCAAAAGCACTCAGAAGTTGAGTCTGATAACA AGAAAAAAAAGATGAAGTTGCCAGGGCAGCCTGAAGAGGGAGAGCCTGAGGACCATGAGGCTCCATCAAAAGGTAAATTCAACTGGAAGGGGACCATTAAAGCTGTTCTGAAACAGGCTCCAGACAAC GAGATATCAGTCAAGAAGTTAAAGAAAAAGGTTATAGCTCAGTACCATGCGGTGATGAGTGACCATCACACATCGGAGGAGGAGCTCCTGGCCATCTTCAACAAGAAGATCAGCAGGAACCCCACCTT TAAGGTGCTGAAGGACAAAGTTAAGCTTCTGAAGTGAGGGCTCTGTTGCGTCACACTCTACCATCCTATTGGCTACTTTCCTCTCTTTGTAAAATGTGTAATGAATTCTAACAGCCGGAAGATTGCTT CCTGAAACTTTTTAAGTTAAGGAAAAAATATATTTTTGTTAAAACTTTTATGAAAAAATAAAATATATCCTTGTCAAATGTC
hide sequence
RefSeq Acc Id:
XM_063272938 ⟹ XP_063129008
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,193 - 76,802,973 (-) NCBI
RefSeq Acc Id:
XM_063272939 ⟹ XP_063129009
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,193 - 76,802,900 (-) NCBI
RefSeq Acc Id:
XM_063272940 ⟹ XP_063129010
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,193 - 76,802,814 (-) NCBI
RefSeq Acc Id:
XM_063272941 ⟹ XP_063129011
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 76,789,193 - 76,802,799 (-) NCBI
RefSeq Acc Id:
NP_001011911 ⟸ NM_001011911
- UniProtKB:
Q6AYK5 (UniProtKB/Swiss-Prot), A6IJU1 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
- Sequence:
MVFFTCNACGESVKKIQVEKHVSICRNCECLSCIDCGKDFWGDDYKNHVKCISEDQKYGGKGYEAKTHKGDVKQQAWIQKINELIKKPNVSPKVRELLQQISAFDNVPRKKAKFQNWMRNSLKVHSDS VLEQVWNIFSEAASSEQDQQPPSHMAKPNTEVPTKVPSTKTNGTTEEQTEAKKNKRERKEERQKSRKKEKKELKLENHQENLKGQKPKKRKKGQEAGHEAGGEDAAEANGAPEKKRARDAQASEEGAD RNGGPAEDADEGPTKTAAGKRKRQKHSEVESDNKKKKMKLPGQPEEGEPEDHEAPSKGKFNWKGTIKAVLKQAPDNEISVKKLKKKVIAQYHAVMSDHHTSEEELLAIFNKKISRNPTFKVLKDKVKL LK
hide sequence
RefSeq Acc Id:
XP_006251149 ⟸ XM_006251087
- Peptide Label:
isoform X2
- UniProtKB:
Q6AYK5 (UniProtKB/Swiss-Prot), A6IJU1 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
- Sequence:
MVFFTCNACGESVKKIQVEKHVSICRNCECLSCIDCGKDFWGDDYKNHVKCISEDQKYGGKGYE AKTHKGDVKQQAWIQKINELIKKPNVSPKVRELLQQISAFDNVPRKKAKFQNWMRNSLKVHSDSVLEQVWNIFSEAASSEQDQQPPSHMAKPNTEVPTKVPSTKTNGTTEEQTEAKKNKRERKEERQK SRKKEKKELKLENHQENLKGQKPKKRKKGQEAGHEAGGEDAAEANGAPEKKRARDAQASEEGADRNGGPAEDADEGPTKTAAGKRKRQKHSEVESDNKKKKMKLPGQPEEGEPEDHEAPSKGKFNWKG TIKAVLKQAPDNEISVKKLKKKVIAQYHAVMSDHHTSEEELLAIFNKKISRNPTFKVLKDKVKLLK
hide sequence
Ensembl Acc Id:
ENSRNOP00000007154 ⟸ ENSRNOT00000007154
Ensembl Acc Id:
ENSRNOP00000073585 ⟸ ENSRNOT00000084093
RefSeq Acc Id:
XP_063129008 ⟸ XM_063272938
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2UI20 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063129009 ⟸ XM_063272939
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2UI20 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063129010 ⟸ XM_063272940
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2UI20 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063129011 ⟸ XM_063272941
- Peptide Label:
isoform X2
- UniProtKB:
Q6AYK5 (UniProtKB/Swiss-Prot), A6IJU1 (UniProtKB/TrEMBL), A0A0G2K5W6 (UniProtKB/TrEMBL)
RGD ID: 13699367
Promoter ID: EPDNEW_R9892
Type: initiation region
Name: Lyar_2
Description: Ly1 antibody reactive
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R9893
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 14 77,321,848 - 77,321,908 EPDNEW
RGD ID: 13699382
Promoter ID: EPDNEW_R9893
Type: initiation region
Name: Lyar_1
Description: Ly1 antibody reactive
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R9892
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 14 77,321,959 - 77,322,019 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2012-12-18
Lyar
Ly1 antibody reactive
Lyar
Ly1 antibody reactive homolog (mouse)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-09-18
Lyar
Ly1 antibody reactive homolog (mouse)
Lyar
Ly1 antibody reactive clone
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-12-06
Lyar
Ly1 antibody reactive clone
Lyar_predicted
Ly1 antibody reactive clone (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Lyar_predicted
Ly1 antibody reactive clone (predicted)
Symbol and Name status set to approved
70820
APPROVED